Markets › Stocks › PARMAX
PA

Parmax Pharma Ltd

NSE: PARMAXBSE: 540359Healthcare
₹50.98
▲ +14.59%
NSE · 15-min delayed
Mkt Cap
₹16 Cr
P / E
-
P / B
-
ROE
-
52W High
₹53.38
52W Low
₹22.60
Key Metrics
Market Cap
₹16 Cr
P / E
-
P / B
-
EV / EBITDA
112.43
ROCE
-84.9%
ROE
-
Debt / Equity
-
Book Value
-
EPS
-
Div Yield
0.0%
Face Value
-
Revenue · ₹ Cr
21
FY20
26
FY21
18
FY22
15
FY23
11
FY24
28
FY25
12
FY26
Net Profit · ₹ Cr
0
FY20
1
FY21
0
FY22
0
FY23
-6
FY24
-2
FY25
-4
FY26
EPS · ₹ per share
₹0.2
FY19
₹1.1
FY20
₹2.0
FY21
₹0.4
FY22
₹-0.3
FY23
₹-15.4
FY24
Q1 2026 snapshot
Sales
₹3 Cr
Operating profit
-
OPM
-
Net profit
₹-1 Cr
EPS
-
Scorecard · 7 axes
Quality
Bad
0/100
Valuation
-
Growth
Bad
-4.9%
Profitability
Bad
-42.5%
Performance
Avg
+22.1%
Entry Point
Bad
96%
Red Flags
Strong
0 flags
Shareholding Pattern
30.8%Promoter
Promoter30.8%
Public69.2%
Quarterly Results · ₹ Cr
QuarterFY24 12QFY25 03QFY25 06QFY25 09QFY25 12QFY26 03Q
Revenue6.34.731.952.544.333.34
Net Profit-0.395-1.495-0.765-2.078-0.732-0.584
NPM %-6.3%-31.6%-39.2%-81.8%-16.9%-17.5%
AlertPre-trade